Claims
- 1. A compound of the formula ##STR5## in which A is --CHOH--C.tbd.C-- and R.sup.1 is hydrogen or lower alkyl.
- 2. 2-(1-Hydroxy-2-octynyl)-5-oxocyclopentaneheptanoic acid, as claimed in claim 1.
- 3. A pharmaceutical composition for relieving a complication arising from abnormally increased physiological availability of prostaglandins in a host, comprising an effective amount of: a compound of formula 1 ##STR6## in which A is --CHOH--C.tbd.C-- and R.sup.1 is hydrogen or lower alkyl, and a pharmaceutically acceptable carrier.
- 4. The pharmaceutical composition of claim 3 in which the compound of formula 1 is 2-(1-hydroxy-2-octynyl)-5-oxocyclopentaneheptanoic acid.
- 5. The pharmaceutical composition of claim 3 in which the compound of formula 1 is present in a unit dose of from 5 to 100 mg.
Parent Case Info
This is a continuation division of application serial no. 545,664 filed Jan. 2, 1975 now U.S. Pat. No. 4004027.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
B491711 |
Kao et al. |
Mar 1976 |
|
3922302 |
Strike |
Nov 1975 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
545664 |
Jan 1975 |
|